Takeda Pharmaceutical Co. Ltd. and its wholly-owned subsidiary Takeda Brazil, have entered an agreement to acquire Multilab for $245.5 million in cash, and as much as $19.6 million in additional future milestone payments. The transaction is expected to close 2Q12.   Multilab, based in Rio Grande do Sul, Brazil, is a mid-sized pharma company with branded generics and OTC pharmaceutical products. Annual revenues were $75.0 million in 2011. Retail sales for the company grew 20% during 2009 – ...